Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA PMA

Implant, hearing, active, middle ear, partially implanted

PMA Number: P990052 · 2022-10-11

ApplicantMed-El Elektromedizinische Gerate GmbH
Decision Date2022-10-11
PMA NumberP990052
Product CodeMPV
Device ClassClass 3
Medical SpecialtyU
Advisory CommitteeEN

Device Summary

Implant, hearing, active, middle ear, partially implanted is the device name listed in this FDA 510(k) record. The listed applicant is Med-El Elektromedizinische Gerate GmbH. It received FDA 510(k) clearance on 2022-10-11. The device is classified under product code MPV. It was reviewed by the EN advisory panel.

Frequently Asked Questions

What is the Implant, hearing, active, middle ear, partially implanted?

Implant, hearing, active, middle ear, partially implanted is a medical device that received FDA 510(k) clearance on 2022-10-11. The listed applicant is Med-El Elektromedizinische Gerate GmbH.

When did Implant, hearing, active, middle ear, partially implanted receive FDA 510(k) clearance?

The clearance date for Implant, hearing, active, middle ear, partially implanted can be found in the official FDA records.

Who is the listed applicant for Implant, hearing, active, middle ear, partially implanted?

The FDA 510(k) record lists Med-El Elektromedizinische Gerate GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Implant, hearing, active, middle ear, partially implanted?

The FDA product code for Implant, hearing, active, middle ear, partially implanted is MPV.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑